The global catheters market size is expected to reach USD 99.30 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period (2024 – 2032).
The global catheters market is experiencing significant growth driven by advancements in medical technologies, the increasing prevalence of chronic diseases, and an aging population. Catheters are flexible tubes inserted into the body to treat or manage various medical conditions, including cardiovascular diseases, urinary tract issues, and neurological disorders. They are used for drainage, administration of fluids, or delivering medication directly to the affected area.
Market Growth Drivers
- Increasing Prevalence of Chronic Diseases: A growing number of individuals suffering from chronic conditions like heart disease, diabetes, and urinary incontinence is driving demand for various catheter types, especially cardiovascular and urinary catheters.
- Aging Population: The global increase in life expectancy is leading to an aging population that requires more medical interventions, including catheterization for managing age-related health issues.
- Technological Advancements: The development of advanced catheter technologies, such as antimicrobial coatings, self-expanding stents, and minimally invasive catheter designs, is enhancing patient comfort and outcomes.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/request-for-sample
Key Companies in the catheters market include
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton Dickson and Company,
- Boston Scientific Corporation
- ConvaTec Group Plc
- Cure Medical LLC
- Edward Lifesciences
Research Scope
- Innovative Technologies: Exploration of novel catheter materials, designs, and coatings, including biodegradable and drug-eluting catheters, is a primary focus.
- Regulatory Standards and Compliance: Research on regulatory issues and compliance with international standards is crucial for ensuring the safety and effectiveness of catheters in various medical applications.
- Clinical Applications: Investigating the expanding use of catheters in clinical settings such as emergency care, ICU, and long-term care facilities.
Future Outlook:
The catheters market is expected to grow steadily, driven by innovations in smart, minimally invasive, and antimicrobial catheters. The rising demand for chronic disease management, an aging population, and advancements in medical technologies will further boost market expansion. Additionally, the increasing shift toward outpatient and homecare services is likely to create new opportunities for catheter use in diverse healthcare settings.
Market Segmentation
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Catheters Market, Product Type Outlook (Revenue – USD Billion, 2019-2032)
- Cardiovascular Catheters
- PTA Balloon Catheters
- Electrophysiology Catheters
- PTCA Balloon Catheters
- IVUS Catheters
- Urology Catheters
- Peritoneal Catheters
- Foley Catheters
- Intermittent Catheters
- External Catheters
- Hemodialysis Catheters
- Intravenous Catheters
- Central Venous Catheters
- Midline Peripheral Catheters
- Peripheral Catheters
- Specialty Catheters
- Thermodilution Catheters
- IUI Catheters
- Wound/Surgical Catheters
- Oximetry Catheters
- Neurovascular Catheters
Catheters Market, Lumen Outlook (Revenue – USD Billion, 2019-2032)
- Single-Lumen
- Double-Lumen
- Triple-Lumen
Catheters Market, Material Outlook (Revenue – USD Billion, 2019-2032)
- Silicone Catheters
- Polyurethane Catheters
- Latex Catheters
- Others
Catheters Market, End-Use Outlook (Revenue – USD Billion, 2019-2032)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Homecare Settings
Catheters Industry Developments
January 2024: Boston Scientific Corporation received FDA approval for its FARAPULSE PFA (Pulsed Field Ablation) System, designed to isolate pulmonary veins for the treatment of drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation (AF). This system offers a novel alternative to traditional thermal ablation therapies. The FARAPULSE PFA System includes the FARAWAVE Ablation Catheter for the procedure.
October 2023: Linear Health Sciences announced FDA approval for the Orchid SRV Safety Released Valve, a catheter designed for use in all IV access procedures. This innovative catheter helps reduce the risk of IV catheter rupture and the need for repairs, offering increased safety for patients in hospital settings.
July 2021: Medtronic plc launched the Prevail DCB (Drug-Coated Balloon) Catheter after receiving CE mark approval. This coronary catheter is used during percutaneous coronary intervention (PCI) to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD). The Prevail DCB is the latest addition to the market for coronary drug-coated balloons.
The catheter market is anticipated to grow at a moderately to rapidly high pace, driven by increased investments in research and development, the prevalence of conditions such as urine incontinence, cardiovascular diseases, and neurovascular disorders, and a rise in catheter usage. Additionally, market expansion is fueled by growing awareness among patients and healthcare professionals about the advantages of catheterization in treating various medical conditions.